Did you know?
ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.
Free Newsletter
Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!
Free Report
For better result, minimum character length is four(4)
Pharma's Bad Reputation Not Always Deserved. More details...
Fed Announcement Drives Biotech Higher. More details...
CBT 200 Gains 40 Points. More details...
CBT 200 Loses 31 Points. More details...
CBT 200 Drops 6 Points. More details...
CBT 200 Takes A Hit. More details...
Biotech Nears All-time High. More details...
An Additional $19 Million To Top Off The Year. More...
CBT 200 Ekes Out New High. More details...
CBT 200 Takes A Small Loss. More details...
ChinaBio® News
Greg Scott Interviewed at BIO-Europe Spring
How to bring your China assets to China in 8 minutes
"Mr. Bio in China."
Mendelspod Interview
Multinational pharma held to a higher standard in China
